Publication | Closed Access
Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia
25
Citations
39
References
2016
Year
NanoparticlesNanomedicineShikonin DerivativesOncologyEngineeringTherapeutic NanomaterialsJacalin-capped Silver NanoparticlesMedicineSilver NanoparticlesNano-drug DeliveryTumor TargetingPharmacologyRadiation OncologyAnticancer Drug
Silver nanoparticles enhance the anticancer efficacy of shikonin derivatives.
| Year | Citations | |
|---|---|---|
Page 1
Page 1